Citeline

Name: Editorially-curated EU biosimilar regulatory event stream within the Pink Sheet European Performance Tracker: per-product filings, CHMP/EMA opinions and commission decisions, cross-referenced against the wider Pink Sheet regulatory-tracking corpus (product reviews, agency leadership, pathways and standards, drug safety, IP and litigation, HTA and payer coverage) spanning US, EU, Asia, LatAm and MEA agencies
Creator: Citeline

CITELINEManage supplier listing

Editorially-curated EU biosimilar regulatory event stream within the Pink Sheet European Performance Tracker: per-product filings, CHMP/EMA opinions and commission decisions, cross-referenced against the wider Pink Sheet regulatory-tracking corpus (product reviews, agency leadership, pathways and standards, drug safety, IP and litigation, HTA and payer coverage) spanning US, EU, Asia, LatAm and MEA agencies

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Citeline and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: PharmaceuticalsPublishing
Instruments: equities
Categories: Regulatory

Dataset card

Type: not stated
Format: Tabular
Volume: Multi-decade archive across six tracked titles, with the EU biosimilar tracker alone covering every EU filing, opinion and approval decision; the wider Pink Sheet estate tracks thousands of pipeline products and thousands of regulatory decisions annually across all major agencies
Users: ~10,000-30,000 named seats across pharma, biotech and investor subscribers (inferred from a 750-employee information-services company operating six branded subscription titles plus a free-trial funnel)
History: 40 years
Update frequency: not stated
Growth: Active — current site with 2025-2026-dated spotlight topics (EU pharma legislation reform, joint clinical assessment, AI, cell & gene therapies) and an active free-trial acquisition funnel
Launched: Pink Sheet as a regulatory-tracking title dates to the 1980s under prior ownership; the current Citeline Insights tracker platform and this EU biosimilar tracker node are a ~2018-2022 digital consolidation of legacy titles
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site